Advertisement

Annals of Surgical Oncology

, Volume 25, Issue 5, pp 1329–1339 | Cite as

Repeat Sentinel Lymph Node Biopsy for Ipsilateral Breast Tumor Recurrence: A Systematic Review of the Results and Impact on Prognosis

  • Ingrid G. M. Poodt
  • Guusje Vugts
  • Robert-Jan Schipper
  • Grard A. P. Nieuwenhuijzen
Breast Oncology

Abstract

Background

During recent years, an increasing number of patients with ipsilateral breast tumor recurrence (IBTR) and previous axillary surgery have undergone repeat sentinel lymph node biopsy (rSLNB). The influence of axillary nodal status on prognosis for IBTR patients remains unclear. This study aimed to evaluate the technical success rate, follow-up assessment, and prognostic value of rSLNB for patients with IBTR.

Methods

A systematic search conducted in MEDLINE, Embase, and the Cochrane Library up to July 2017 included all studies on rSLNB in IBTR.

Results

A total of 34 articles describing 1761 patients were identified. A repeat sentinel lymph node (rSLN) was successfully harvested from 64.3% of the patients with IBTR, and the rate was significantly higher for the patients who had a previous SLNB than for those who had a previous axillary lymph node dissection (ALND) (75.7% vs. 46.1%; P < 0.0001). The rSLN was tumor-positive for 18.2% of the rSLNs, 40% of which were harvested in basins other than the ipsilateral axilla. The negative predictive value of the rSLNB was 96.5%. Overall survival, reported for 21.5% of the patients, was 95.2% after a mean follow-up period of 29.6 months.

Conclusion

The prognostic impact of rSLN-positive versus rSLN-negative IBTR remains unclear. Further studies are needed to fill in the gap in the management of lymph nodes for patients with IBTR. However, based on the current evidence, rSLNB is feasible for 64% of patients, especially after previous SLNB. With a negative predictive value of 96.5%, rSLNB appears to be highly specific, with substantial advantages over ipsilateral ALND in IBTR.

Notes

Acknowledgment

The research conducted for this study complies with the current laws of The Netherlands.

Disclosures

There are no conflicts of interest.

Supplementary material

10434_2018_6358_MOESM1_ESM.docx (385 kb)
Supplementary material 1 (DOCX 385 kb)

References

  1. 1.
    Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.CrossRefPubMedGoogle Scholar
  2. 2.
    Houssami N, Macaskill P, Marinovich ML, Morrow M. The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol. 2014;21:717–30.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Arriagada R, Le MG, Guinebretiere JM, Dunant A, Rochard F, Tursz T. Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol. 2003;14:1617–22.CrossRefPubMedGoogle Scholar
  4. 4.
    Burger AE, Pain SJ, Peley G. Treatment of recurrent breast cancer following breast conserving surgery. Breast J. 2013;19:310–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Vugts G, Maaskant-Braat AJ, Voogd AC, et al. Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer. Breast Cancer Res Treat. 2015;153:549–56.CrossRefPubMedGoogle Scholar
  6. 6.
    Nationaal Borstkanker Overleg Nederland (NABON). Richtlijn behandeling van het mammacarcinoom. http://www.oncoline.nl. Accessed 2 Mar 2012.
  7. 7.
    Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology Clinical practice guideline update. J Clin Oncol. 2016; 32: JCO1365CrossRefGoogle Scholar
  8. 8.
    Moossdorff M, van Roozendaal LM, Strobbe LJ, et al. Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research. J Natl Cancer Inst. 2014. doi:  https://doi.org/10.1093/jnci/dju288 PubMedPubMedCentralGoogle Scholar
  9. 9.
    Intra M, Viale G, Vila J, et al. Second axillary sentinel lymph node biopsy for breast tumor recurrence: experience of the European Institute of Oncology. Ann Surg Oncol. 2015;22:2372–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Moossdorff M, Vugts G, Maaskant-Braat AJ, et al. Contralateral lymph node recurrence in breast cancer: regional event rather than distant metastatic disease: a systematic review of the literature. Eur J Surg Oncol. 2015;41:1128–36.CrossRefPubMedGoogle Scholar
  11. 11.
    Morcos B, Jaradat I, El-Ghanem M. Characteristics of and therapeutic options for contralateral axillary lymph node metastasis in breast cancer. Eur J Surg Oncol. 2011;37:418–21.CrossRefPubMedGoogle Scholar
  12. 12.
    Maaskant-Braat AJ, Voogd AC, Roumen RM, Nieuwenhuijzen GA. Repeat sentinel node biopsy in patients with locally recurrent breast cancer: a systematic review and meta-analysis of the literature. Breast Cancer Res Treat. 2013;138:13–20.CrossRefPubMedGoogle Scholar
  13. 13.
    Lim I, Shim J, Goyenechea M, Kim CK, Krynyckyi BR. Drainage across midline to sentinel nodes in the contralateral axilla in breast cancer. Clin Nucl Med. 2004;29:346–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Sood A, Youssef IM, Heiba SI, et al. Alternative lymphatic pathway after previous axillary node dissection in recurrent/primary breast cancer. Clin Nucl Med. 2004;29:698–702.CrossRefPubMedGoogle Scholar
  15. 15.
    Agarwal A, Heron DE, Sumkin J, Falk J. Contralateral uptake and metastases in sentinel lymph node mapping for recurrent breast cancer. J Surg Oncol. 2005;92:4–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Dinan D, Nagle CE, Pettinga J. Lymphatic mapping and sentinel node biopsy in women with an ipsilateral second breast carcinoma and a history of breast and axillary surgery. Am J Surg. 2005;190:614–7.CrossRefPubMedGoogle Scholar
  17. 17.
    Tada K, Nishimura S, Miyagi Y, et al. The effect of an old surgical scar on sentinel node mapping in patients with breast cancer: a report of five cases. Eur J Surg Oncol. 2005;31:840–4.CrossRefPubMedGoogle Scholar
  18. 18.
    Boughey JC, Ross MI, Babiera GV, et al. Sentinel lymph node surgery in locally recurrent breast cancer. Clin Breast Cancer. 2006;7:248–53.CrossRefPubMedGoogle Scholar
  19. 19.
    Jackson BM, Kim S, Davidson R, Schuchter L, Acs G, Czerniecki BJ. Repeat operative sentinel lymph node biopsy. Clin Breast Cancer. 2006;6:530–4.CrossRefPubMedGoogle Scholar
  20. 20.
    Newman EA, Cimmino VM, Sabel MS, et al. Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy. Ann Surg Oncol. 2006;13:52–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Roumen RMH, Kuijt GP, Liem IH. Lymphatic mapping and sentinel node harvesting in patients with recurrent breast cancer. Eur J Surg Oncol. 2006;32:1076–81.CrossRefPubMedGoogle Scholar
  22. 22.
    Taback B, Nguyen P, Hansen N, Edwards GK, Conway K, Giuliano AE. Sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapy. Ann Surg Oncol. 2006;13:1099–104.CrossRefPubMedGoogle Scholar
  23. 23.
    Barone JL, Feldman SM, Estabrook A, Tartter PI, Rosenbaum Smith SM, Boolbol SK. Reoperative sentinel lymph node biopsy in patients with locally recurrent breast cancer. Am J Surg. 2007;194:491–3.CrossRefPubMedGoogle Scholar
  24. 24.
    Port ER, Garcia-Etienne CA, Park J, Fey J, Borgen PI, Cody IHS. Reoperative sentinel lymph node biopsy: a new frontier in the management of ipsilateral breast tumor recurrence. Ann Surg Oncol. 2007;14:2209–14.CrossRefPubMedGoogle Scholar
  25. 25.
    Axelsson CK, Jonsson PE. Sentinel lymph node biopsy in operations for recurrent breast cancer. Eur J Surg Oncol. 2008;34:626–30.CrossRefPubMedGoogle Scholar
  26. 26.
    Cox CE, Furman BT, Kiluk JV, et al. Use of reoperative sentinel lymph node biopsy in breast cancer patients. J Am Coll Surg. 2008;207:57–61.CrossRefPubMedGoogle Scholar
  27. 27.
    Karam A, Stempel M, Cody HS III, Port ER. Reoperative sentinel lymph node biopsy after previous mastectomy. J Am Coll Surg. 2008;207:543–8.CrossRefPubMedGoogle Scholar
  28. 28.
    Koizumi M, Koyama M, Tada K, et al. The feasibility of sentinel node biopsy in the previously treated breast. Eur J Surg Oncol. 2008;34:365–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Schrenk P, Tausch C, Wayand W. Lymphatic mapping in patients with primary or recurrent breast cancer following previous axillary surgery. Eur J Surg Oncol. 2008;34:851–6.CrossRefPubMedGoogle Scholar
  30. 30.
    Tasevski R, Gogos AJ, Mann GB. Reoperative sentinel lymph node biopsy in ipsilateral breast cancer relapse. Breast. 2009;18:322–6.CrossRefPubMedGoogle Scholar
  31. 31.
    van der Ploeg IM, Oldenburg HS, Rutgers EJ, et al. Lymphatic drainage patterns from the treated breast. Ann Surg Oncol. 2010;17:1069–75.CrossRefPubMedGoogle Scholar
  32. 32.
    Vicente DA, Henry LR, Hahm G, Soballe PW, Smart D. Axillary sentinel lymph node biopsy after mastectomy: a case report. World J Surg Oncol. 2010;8:59CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Derkx F, Maaskant-Braat AJ, van der Sangen MJ, et al. Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedure. Eur J Surg Oncol. 2010;36:646–51.CrossRefPubMedGoogle Scholar
  34. 34.
    Yamashita T, Fujita T, Hayashi H, et al. Detection of parasternal metastatic lymph nodes by sentinel lymph node methods in a patient with recurrence in the conserved breast. Breast Cancer Tokyo Jpn. 2014;21:246–8.CrossRefGoogle Scholar
  35. 35.
    Hattori M, Nishimura S, Tada K, et al. Reoperative sentinel lymph node biopsy for ipsilateral breast tumor recurrence after previous axillary lymph node dissection: report of a case. Surg Today. 2011;41:247–50.CrossRefPubMedGoogle Scholar
  36. 36.
    Kaur P, Kiluk JV, Meade T, et al. Sentinel lymph node biopsy in patients with previous ipsilateral complete axillary lymph node dissection. Ann Surg Oncol. 2011;18:727–32.CrossRefPubMedGoogle Scholar
  37. 37.
    Tokmak H, Kaban K, Muslumanoglu M, Demirel M, Aktan S. Management of sentinel node re-mapping in patients who have second or recurrent breast cancer and had previous axillary procedures. World J Surg Oncol. 2014;12:205.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Cordoba O, Perez-Ceresuela F, Espinosa-Bravo M, et al. Detection of sentinel lymph node in breast cancer recurrence may change adjuvant treatment decision in patients with breast cancer recurrence and previous axillary surgery. Breast. 2014;23:460–5.CrossRefPubMedGoogle Scholar
  39. 39.
    Matsumoto A, Jinno H, Takahashi M, Hayashida T, Kitagawa Y. Technical feasibility and validity of sentinel lymph node biopsy after ipsilateral breast tumor recurrence. Eur J Surg Oncol. 2016;42:S132.CrossRefGoogle Scholar
  40. 40.
    Uth CC, Christensen MH, Oldenbourg MH, et al. Sentinel lymph node dissection in locally recurrent breast cancer. Ann Surg Oncol. 2015;22:2526–31.CrossRefPubMedGoogle Scholar
  41. 41.
    Karanlik H, Ozgur I, Kilic B, et al. Sentinel lymph node biopsy and aberrant lymphatic drainage in recurrent breast cancer: findings likely to change treatment decisions. J Surg Oncol. 2016;114:796–802.CrossRefPubMedGoogle Scholar
  42. 42.
    Borrelli P, Donswijk ML, Stokkel MP, et al. Contribution of SPECT/CT for sentinel node localization in patients with ipsilateral breast cancer relapse. Eur J Nucl Med Mol Imaging. 2017;44:630–7.CrossRefPubMedGoogle Scholar
  43. 43.
    Folli S, Falco G, Mingozzi M, et al. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study. Minerva Chir. 2016;71:73–9.PubMedGoogle Scholar
  44. 44.
    Johnson J, Esserman L, Ewing C, Alvarado M, Park C, Fowble B. Sentinel lymph node mapping in post-mastectomy chest wall recurrences: influence on radiation treatment fields and outcome. Ann Surg Oncol. 2016;23:715–21.CrossRefPubMedGoogle Scholar
  45. 45.
    Fisher B, Anderson S, Fisher ER, et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet. 1991;338:327–31.CrossRefPubMedGoogle Scholar
  46. 46.
    Veronesi U, Marubini E, Del Vecchio M, et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst. 1995;87:19–27.CrossRefPubMedGoogle Scholar
  47. 47.
    Wapnir IL, Aebi S, Geyer CE, et al. A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37. Clin Breast Cancer. 2008;8:287–92.CrossRefPubMedGoogle Scholar
  48. 48.
    Anderson SJ, Wapnir I, Dignam JJ, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical adjuvant breast and bowel project protocols of node-negative breast cancer. J Clin Oncol. 2009;27:2466–73.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Voogd AC, van Oost FJ, Rutgers EJ, et al. Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer. 2005;41:2637–44.CrossRefPubMedGoogle Scholar
  50. 50.
    Wapnir IL, Anderson SJ, Mamounas EP, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National surgical adjuvant breast and bowel project node-positive adjuvant breast cancer trials. J Clin Oncol. 2006;24:2028–37.CrossRefPubMedGoogle Scholar
  51. 51.
    Kothari MS, Rusby JE, Agusti AA, MacNeill FA. Sentinel lymph node biopsy after previous axillary surgery: a review. Eur J Surg Oncol. 2012;38:8–15.CrossRefPubMedGoogle Scholar
  52. 52.
    Ikeda T. Re-sentinel node biopsy after previous breast and axillary surgery. Surg Today. 2014;44:2015–21.CrossRefPubMedGoogle Scholar
  53. 53.
    Vugts G, Maaskant-Braat AJ, Voogd AC, et al. Improving the success rate of repeat sentinel node biopsy in recurrent breast cancer. Ann Surg Oncol. 2015;22(Suppl 3):S529–35.CrossRefPubMedGoogle Scholar
  54. 54.
    Valdes-Olmos RA, Jansen L, Hoefnagel CA, et al. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification. J Nucl Med. 2000;41:1500–6.PubMedGoogle Scholar
  55. 55.
    Ugras S, Matsen C, Eaton A, Stempel M, Morrow M, Cody HS. Reoperative sentinel lymph node biopsy is feasible for locally recurrent breast cancer, but is it worthwhile? Ann Surg Oncol. 2016;23:744–8.CrossRefPubMedGoogle Scholar
  56. 56.
    Aebi S, Gelber S, Anderson SJ, et al. Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial. Lancet Oncol. 2014;15:156–63.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Department of SurgeryCatharina Hospital EindhovenEindhovenThe Netherlands

Personalised recommendations